Red
Brand Name(s):
Indication:Anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) in adults
Rationale:1,2,3
Considered:Sep-15
Review Date:Jul-21
Comments:
NICE TA 395 Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer
June 2016